MC2263A1 - Aminobenzodiazepines et leurs sels pharmaceutiquement acceptables - Google Patents

Aminobenzodiazepines et leurs sels pharmaceutiquement acceptables

Info

Publication number
MC2263A1
MC2263A1 MC912193A MC2193A MC2263A1 MC 2263 A1 MC2263 A1 MC 2263A1 MC 912193 A MC912193 A MC 912193A MC 2193 A MC2193 A MC 2193A MC 2263 A1 MC2263 A1 MC 2263A1
Authority
MC
Monaco
Prior art keywords
aminobenzodiazepines
pharmaceutically acceptable
acceptable salts
salts
pharmaceutically
Prior art date
Application number
MC912193A
Other languages
English (en)
French (fr)
Inventor
Roberte Bellemin Anne
Valentine Earley James
Hsu Ming-Chu
Yik-Kai Tam Steve
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2263A1 publication Critical patent/MC2263A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MC912193A 1990-06-18 1991-06-17 Aminobenzodiazepines et leurs sels pharmaceutiquement acceptables MC2263A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/539,500 US5141735A (en) 1990-06-18 1990-06-18 Substituted amino-benzodiazepines having anitviral activity

Publications (1)

Publication Number Publication Date
MC2263A1 true MC2263A1 (fr) 1993-04-26

Family

ID=24151485

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912193A MC2263A1 (fr) 1990-06-18 1991-06-17 Aminobenzodiazepines et leurs sels pharmaceutiquement acceptables

Country Status (21)

Country Link
US (1) US5141735A (ja)
EP (1) EP0462522A1 (ja)
JP (1) JPH04230280A (ja)
KR (1) KR920000746A (ja)
CN (1) CN1057462A (ja)
AU (1) AU7846991A (ja)
BR (1) BR9102489A (ja)
CA (1) CA2044694A1 (ja)
CS (1) CS182991A3 (ja)
FI (1) FI912927A (ja)
HU (1) HUT58069A (ja)
IE (1) IE912061A1 (ja)
IL (1) IL98499A0 (ja)
IS (1) IS3718A7 (ja)
LT (1) LTIP863A (ja)
MC (1) MC2263A1 (ja)
MX (1) MX26267A (ja)
NO (1) NO912346L (ja)
NZ (1) NZ238552A (ja)
PT (1) PT98007A (ja)
ZA (1) ZA914202B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US5679688A (en) * 1992-03-11 1997-10-21 Narhex Limited Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
SI9300288A (sl) * 1992-06-16 1993-12-31 Hoffmann La Roche Benzodiazepini
EP0668766A1 (en) * 1992-10-23 1995-08-30 University Of Massachusetts Medical Center Small molecule inhibition of rna/ligand binding
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
US5578573A (en) * 1995-01-20 1996-11-26 Houghten Pharmaceuticals, Inc. Viral integrase inhibiting peptides
CA2269078C (en) * 1996-10-16 2012-01-24 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
GB0015904D0 (en) 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
JP2004529851A (ja) * 2000-09-12 2004-09-30 ジーントロール バイオセラピューティクス， インコーポレイテッド ヒトサイトカインの混合物を含む組成物およびその産生方法
US20020150541A1 (en) * 2000-09-12 2002-10-17 Gene Trol Biotherapeutics, Inc. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
JP2005089298A (ja) * 2001-09-18 2005-04-07 Japan Tobacco Inc ナフタレン化合物及びその医薬用途
CA2460341A1 (en) * 2001-10-05 2003-04-17 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
CA2536041A1 (en) * 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
KR100652975B1 (ko) * 2005-03-17 2006-12-01 유해일 옥수숫대 반화학 기계펄프의 제조방법
WO2012125787A1 (en) 2011-03-17 2012-09-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY CBFβ AND RUNX1 PROTEINS
EP3535253A1 (en) * 2016-11-01 2019-09-11 H. Hoffnabb-La Roche Ag 1,3-dihydro-1,4-benzodiazepine-2-thiones for the treatment of cns related diseases
US11229662B2 (en) 2016-11-15 2022-01-25 The Schepens Eye Research Institute, Inc. Compositions and methods for the treatment of aberrant angiogenesis
US11583497B2 (en) 2017-11-14 2023-02-21 The Schepens Eye Research Institute, Inc. Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
US11739326B2 (en) 2017-11-14 2023-08-29 Massachusetts Eye And Ear Infirmary RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3267110A (en) * 1960-06-03 1966-08-16 Smith Kline French Lab Trifluoromethyl substituted o-aminophenyl ketones
NL131733C (ja) * 1961-06-20
NL126389C (ja) * 1962-07-10
US3330481A (en) * 1965-03-18 1967-07-11 Filtra Inc Dispersant dispenser of an absorbent or adsorbent material
CH502354A (de) * 1967-03-08 1971-01-31 Hoffmann La Roche Verfahren zur Herstellung von Benzodiazepin-Derivaten
JPS4843755B1 (ja) * 1969-06-26 1973-12-20
ZA698792B (en) * 1968-12-30 1971-03-31 Fujisawa Pharmaceutical Co Novel antibiotic and derivatives and production thereof
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
US3954728A (en) * 1972-07-13 1976-05-04 Hoffman-La Roche Inc. Preparation of triazolo benzodiazepines and novel compounds
DE3619202A1 (de) * 1986-06-07 1987-12-10 Merz & Co Gmbh & Co Verwendung von avaron und avarol sowie von derivaten davon zur bekaempfung von aids und arc
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
GB8806449D0 (en) * 1988-03-18 1988-04-20 Janssen Pharmaceutica Nv Antiviral hexahydroimiazo(1 4)benzodiazepin-2-ones

Also Published As

Publication number Publication date
IS3718A7 (is) 1991-12-19
FI912927A (fi) 1991-12-19
KR920000746A (ko) 1992-01-29
CS182991A3 (en) 1992-04-15
IL98499A0 (en) 1992-07-15
CA2044694A1 (en) 1991-12-19
US5141735A (en) 1992-08-25
FI912927A0 (fi) 1991-06-17
AU7846991A (en) 1992-01-02
JPH04230280A (ja) 1992-08-19
IE912061A1 (en) 1991-12-18
ZA914202B (en) 1992-03-25
CN1057462A (zh) 1992-01-01
HUT58069A (en) 1992-01-28
BR9102489A (pt) 1992-01-21
LTIP863A (en) 1995-03-27
NO912346D0 (no) 1991-06-17
HU912005D0 (en) 1991-12-30
NZ238552A (en) 1993-08-26
EP0462522A1 (en) 1991-12-27
MX26267A (es) 1993-09-01
PT98007A (pt) 1992-03-31
NO912346L (no) 1991-12-19

Similar Documents

Publication Publication Date Title
MC2263A1 (fr) Aminobenzodiazepines et leurs sels pharmaceutiquement acceptables
LU91147I2 (fr) Pemetrexed et ses sels pharmaceutiquement acceptables.
LU91452I2 (fr) "Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)"
LU90484I2 (fr) Novorapid - insuline asparte et ses sels et derives pharmaceutiquement acceptables
LU90736I2 (fr) Agenerase-amprenavir et ses d-riv-s pharmaceutiquement acceptables
LU90069I2 (fr) Lercanidipine et ses sels et dérivés pharmaceutiquement acceptables (Zanidip)
LU91291I2 (fr) Deferasirox et ses sels pharmaceutiquement acceptables (EXJADEr)
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
LU91039I2 (fr) Proteq flu et ses dérivés pharmaceutiquement acceptables
LU88576I2 (fr) RISPERIDONE et ses sels pharmaceutiquement acceptables (Risperdal R)
LU91205I2 (fr) Ciclesonide et ses dérivés pharmaceutiquement acceptables (alvesco)
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
TR26729A (tr) Sekil hafizasi etkili cerrahi igneler
LU90844I2 (fr) es Riamet et ses d-riv-s pharmaceutiquement acceptabl
NO922291D0 (no) 7-azaisoindolinyl-kinolon- og naftyridonkarboksylsyrederivater
LU91345I2 (fr) Rufinamide et ses sels pharmaceutiquement acceptables (inovelon)
MC2290A1 (fr) Benzoquinazolines pharmaceutiquement actives
FI930577A (fi) Vaccin och behandlingsmetod foer hiv-infektion
FI933799A (fi) Foerbaettrad haorborttagningsapparat med roterbart huvud och flera fjaedrar
FI914598A (fi) Foerfarande i en med optisk princip fungerande ankomstkoppling
LU88574I2 (fr) CEFEPIME et ses sels pharmaceutiquement acceptables (Maxipime R)
FI930674A (fi) Terapeutiska aemnen
NO922934D0 (no) Cykloheksan- og tetrahydropyranderivater
KR930012877U (ko) 저금통
LU90110I2 (fr) Penciclovir et ses dérivés pharmaceutiquement acceptables